Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18


Multilayer intraclonal heterogeneity in chronic myelomonocytic leukemia.

Beke A, Laplane L, Riviere J, Yang Q, Torres-Martin M, Dayris T, Rameau P, Saada V, Bilhou-Nabera C, Hurtado A, Lordier L, Vainchenker W, Figueroa ME, Droin N, Solary E.

Haematologica. 2019 May 2. pii: haematol.2018.208488. doi: 10.3324/haematol.2018.208488. [Epub ahead of print]


TET2 Deficiency Causes Germinal Center Hyperplasia, Impairs Plasma Cell Differentiation, and Promotes B-cell Lymphomagenesis.

Dominguez PM, Ghamlouch H, Rosikiewicz W, Kumar P, Béguelin W, Fontán L, Rivas MA, Pawlikowska P, Armand M, Mouly E, Torres-Martin M, Doane AS, Calvo Fernandez MT, Durant M, Della-Valle V, Teater M, Cimmino L, Droin N, Tadros S, Motanagh S, Shih AH, Rubin MA, Tam W, Aifantis I, Levine RL, Elemento O, Inghirami G, Green MR, Figueroa ME, Bernard OA, Aoufouchi S, Li S, Shaknovich R, Melnick AM.

Cancer Discov. 2018 Dec;8(12):1632-1653. doi: 10.1158/2159-8290.CD-18-0657. Epub 2018 Oct 1.


Whole exome sequencing in a case of sporadic multiple meningioma reveals shared NF2, FAM109B, and TPRXL mutations, together with unique SMARCB1 alterations in a subset of tumor nodules.

Torres-Martín M, Kusak ME, Isla A, Burbano RR, Pinto GR, Melendez B, Castresana JS, Rey JA.

Cancer Genet. 2015 Jun;208(6):327-32. doi: 10.1016/j.cancergen.2015.03.012. Epub 2015 Apr 11.


Genome-wide methylation analysis in vestibular schwannomas shows putative mechanisms of gene expression modulation and global hypomethylation at the HOX gene cluster.

Torres-Martín M, Lassaletta L, de Campos JM, Isla A, Pinto GR, Burbano RR, Melendez B, Castresana JS, Rey JA.

Genes Chromosomes Cancer. 2015 Apr;54(4):197-209. doi: 10.1002/gcc.22232. Epub 2014 Dec 23.


Global expression profile in low grade meningiomas and schwannomas shows upregulation of PDGFD, CDH1 and SLIT2 compared to their healthy tissue.

Torres-Martin M, Lassaletta L, Isla A, De Campos JM, Pinto GR, Burbano RR, Castresana JS, Melendez B, Rey JA.

Oncol Rep. 2014 Dec;32(6):2327-34. doi: 10.3892/or.2014.3526. Epub 2014 Oct 3.


Homozygous deletion of TNFRSF4, TP73, PPAP2B and DPYD at 1p and PDCD5 at 19q identified by multiplex ligation-dependent probe amplification (MLPA) analysis in pediatric anaplastic glioma with questionable oligodendroglial component.

Torres-Martín M, Peña-Granero C, Carceller F, Gutiérrez M, Burbano RR, Pinto GR, Castresana JS, Melendez B, Rey JA.

Mol Cytogenet. 2014 Jan 6;7(1):1. doi: 10.1186/1755-8166-7-1.


Gene expression analysis of aberrant signaling pathways in meningiomas.

Torres-Martín M, Martinez-Glez V, Peña-Granero C, Isla A, Lassaletta L, DE Campos JM, Pinto GR, Burbano RR, Meléndez B, Castresana JS, Rey JA.

Oncol Lett. 2013 Jul;6(1):275-279. Epub 2013 May 23.


NF2 genetic alterations in sporadic vestibular schwannomas: clinical implications.

Lassaletta L, Torres-Martín M, Peña-Granero C, Roda JM, Santa-Cruz-Ruiz S, Castresana JS, Gavilan J, Rey JA.

Otol Neurotol. 2013 Sep;34(7):1355-61. doi: 10.1097/MAO.0b013e318298ac79.


Global profiling in vestibular schwannomas shows critical deregulation of microRNAs and upregulation in those included in chromosomal region 14q32.

Torres-Martin M, Lassaletta L, de Campos JM, Isla A, Gavilan J, Pinto GR, Burbano RR, Latif F, Melendez B, Castresana JS, Rey JA.

PLoS One. 2013 Jun 11;8(6):e65868. doi: 10.1371/journal.pone.0065868. Print 2013.


Microarray analysis of gene expression in vestibular schwannomas reveals SPP1/MET signaling pathway and androgen receptor deregulation.

Torres-Martin M, Lassaletta L, San-Roman-Montero J, De Campos JM, Isla A, Gavilan J, Melendez B, Pinto GR, Burbano RR, Castresana JS, Rey JA.

Int J Oncol. 2013 Mar;42(3):848-62. doi: 10.3892/ijo.2013.1798. Epub 2013 Jan 24.


DNA copy gains of tumor-related genes in vestibular schwannoma.

Lassaletta L, Torres-Martín M, San-Román-Montero J, Castresana JS, Gavilán J, Rey JA.

Eur Arch Otorhinolaryngol. 2013 Sep;270(9):2433-8. doi: 10.1007/s00405-012-2269-z. Epub 2012 Nov 21.


Expression analysis of tumor-related genes involved in critical regulatory pathways in schwannomas.

Torres-Martín M, Martinez-Glez V, Peña-Granero C, Lassaletta L, Isla A, de Campos JM, Pinto GR, Burbano RR, Meléndez B, Castresana JS, Rey JA.

Clin Transl Oncol. 2013 May;15(5):409-11. doi: 10.1007/s12094-012-0937-5. Epub 2012 Oct 2.


The molecular biology of vestibular schwannomas and its association with hearing loss: a review.

Celis-Aguilar E, Lassaletta L, Torres-Martín M, Rodrigues FY, Nistal M, Castresana JS, Gavilan J, Rey JA.

Genet Res Int. 2012;2012:856157. doi: 10.1155/2012/856157. Epub 2012 Feb 20.


Cyclin D1 expression and facial function outcome after vestibular schwannoma surgery.

Lassaletta L, Del Rio L, Torres-Martin M, Rey JA, Patrón M, Madero R, Roda JM, Gavilan J.

Otol Neurotol. 2011 Jan;32(1):136-40. doi: 10.1097/MAO.0b013e3182001cc8.


Genomic deletions at 1p and 14q are associated with an abnormal cDNA microarray gene expression pattern in meningiomas but not in schwannomas.

Martínez-Glez V, Alvarez L, Franco-Hernández C, Torres-Martin M, de Campos JM, Isla A, Vaquero J, Lassaletta L, Castresana JS, Casartelli C, Rey JA.

Cancer Genet Cytogenet. 2010 Jan 1;196(1):1-6. doi: 10.1016/j.cancergencyto.2009.08.003.


cDNA microarray expression profile in vestibular schwannoma: correlation with clinical and radiological features.

Lassaletta L, Martínez-Glez V, Torres-Martín M, Rey JA, Gavilán J.

Cancer Genet Cytogenet. 2009 Oct 15;194(2):125-7. doi: 10.1016/j.cancergencyto.2009.06.016. No abstract available.


[Identification of genetic alterations by multiple ligation-dependent probe amplification (MLPA) analysis in oligodendrogliomas].

Franco-Hernández C, Martínez-Glez V, Torres-Martín M, de Campos JM, Isla A, Vaquero J, Casartelli C, Rey JA.

Neurocirugia (Astur). 2009 Apr;20(2):117-23. Spanish.


Mutational analysis of the CITED4 gene in glioblastomas.

Torres-Martín M, Franco-Hernandez C, Martinez-Glez V, de Campos JM, Isla A, Casartelli C, Rey JA.

Cancer Genet Cytogenet. 2008 Sep;185(2):114-6. doi: 10.1016/j.cancergencyto.2008.05.013. No abstract available.


Supplemental Content

Loading ...
Support Center